K2M’s President and CEO Eric Major noted in the report, “FDA clearance of MESA 2 is a milestone event for K2M that further enhances our position in the global spine surgery market.” The MESA 2 is the next generation of the company’s established MESA spinal device.
To learn more about K2M and their wide variety of medical devices, click here.
